Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fumitaka Koga

Showing results (11-20 of 177) with videos related to

Pageof 18
Sort By:
Cell Cycle (Georgetown, Tex.)|May 26, 2007
Low dose geldanamycin inhibits hepatocyte growth factor and hypoxia-stimulated invasion of cancer cellsFumitaka Koga, Shinji Tsutsumi, Leonard M Neckers
International Journal of Molecular Sciences|October 3, 2018
Impact of Sarcopenia as a Prognostic Biomarker of Bladder CancerHiroshi Fukushima, Kosuke Takemura, Hiroaki Suzuki, et al.
EXCLI Journal|November 25, 2015
Heat shock protein 90 targeting therapy: state of the art and future perspectiveManabu Tatokoro, Fumitaka Koga, Soichiro Yoshida, et al.
Frontiers in Oncology|December 15, 2025
Case Report: Zinc deficiency as a modifiable risk factor for enfortumab vedotin-induced cutaneous adverse eventsAya Nishizawa, Masaya Itoh, Midori Inoue, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 31, 2014
Role of diffusion-weighted magnetic resonance imaging as an imaging biomarker of urothelial carcinomaSoichiro Yoshida, Fumitaka Koga, Hitoshi Masuda, et al.
Expert Opinion on Therapeutic Targets|April 2, 2019
Heat shock factor 1 (HSF1)-targeted anticancer therapeutics: overview of current preclinical progressToshiki Kijima, Thomas Prince, Len Neckers, et al.
Cureus|December 9, 2025
Multifocal Dural Arteriovenous Fistula Formation Following Successful Endovascular Treatment of a Traumatic Direct Carotid Cavernous FistulaFumitaka Koga, Atsushi Ogata, Kenji Suzuyama, et al.
BMJ Oncology|February 4, 2026
Bladder-sparing strategies for non-muscle-invasive bladder cancer after bacillus Calmette-Guérin failure: a systematic reviewTakahiko Soma, Kosuke Takemura, Masahiro Toide, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 22, 2009
Gasless single-port access endoscopic surgery in urology: minimum incision endoscopic surgery, MIESKazunori Kihara, Satoru Kawakami, Yasuhisa Fujii, et al.
Clinical Genitourinary Cancer|September 8, 2016
Postoperative Changes in Skeletal Muscle Mass Predict Survival of Patients With Metastatic Renal Cell Carcinoma Undergoing Cytoreductive NephrectomyHiroshi Fukushima, Yasukazu Nakanishi, Madoka Kataoka, et al.
Pageof 18

Showing results (11-20 of 177) with videos related to

Sort By:
Pageof 18
Cell Cycle (Georgetown, Tex.)|May 26, 2007
Low dose geldanamycin inhibits hepatocyte growth factor and hypoxia-stimulated invasion of cancer cellsFumitaka Koga, Shinji Tsutsumi, Leonard M Neckers
International Journal of Molecular Sciences|October 3, 2018
Impact of Sarcopenia as a Prognostic Biomarker of Bladder CancerHiroshi Fukushima, Kosuke Takemura, Hiroaki Suzuki, et al.
EXCLI Journal|November 25, 2015
Heat shock protein 90 targeting therapy: state of the art and future perspectiveManabu Tatokoro, Fumitaka Koga, Soichiro Yoshida, et al.
Frontiers in Oncology|December 15, 2025
Case Report: Zinc deficiency as a modifiable risk factor for enfortumab vedotin-induced cutaneous adverse eventsAya Nishizawa, Masaya Itoh, Midori Inoue, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 31, 2014
Role of diffusion-weighted magnetic resonance imaging as an imaging biomarker of urothelial carcinomaSoichiro Yoshida, Fumitaka Koga, Hitoshi Masuda, et al.
Expert Opinion on Therapeutic Targets|April 2, 2019
Heat shock factor 1 (HSF1)-targeted anticancer therapeutics: overview of current preclinical progressToshiki Kijima, Thomas Prince, Len Neckers, et al.
Cureus|December 9, 2025
Multifocal Dural Arteriovenous Fistula Formation Following Successful Endovascular Treatment of a Traumatic Direct Carotid Cavernous FistulaFumitaka Koga, Atsushi Ogata, Kenji Suzuyama, et al.
BMJ Oncology|February 4, 2026
Bladder-sparing strategies for non-muscle-invasive bladder cancer after bacillus Calmette-Guérin failure: a systematic reviewTakahiko Soma, Kosuke Takemura, Masahiro Toide, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 22, 2009
Gasless single-port access endoscopic surgery in urology: minimum incision endoscopic surgery, MIESKazunori Kihara, Satoru Kawakami, Yasuhisa Fujii, et al.
Clinical Genitourinary Cancer|September 8, 2016
Postoperative Changes in Skeletal Muscle Mass Predict Survival of Patients With Metastatic Renal Cell Carcinoma Undergoing Cytoreductive NephrectomyHiroshi Fukushima, Yasukazu Nakanishi, Madoka Kataoka, et al.
Pageof 18